Combination of candesartan cilexetil hydrochlorothiazide 8/12.5 mg has a similar antihypertensive effect and is better tolerated than lisinopril/hydrochlorothiazide 10/12.5 MG

被引：0

作者：

McInnes, GT

Istad, H

Keinänen-Kiukaanniemi, S

van Mierlo, HFCM

机构：

[1] Dept Med & Therapeut, Glasgow, Lanark, Scotland

[2] Theresegt Legesenter, Oslo, Norway

[3] Dept Publ Hlth Sci, Oulu, Finland

来源：

JOURNAL OF HYPERTENSION | 1998年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

P31011

引用

页码：S232 / S232

页数：1

共 50 条

[1] The combination tablet of candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg has a tolerability profile similar to that of placebo
Belcher, G
Lunde, H
Elmfeldt, D
George, M
[J]. JOURNAL OF HYPERTENSION, 2000, 18 : S94 - S94
[2] A comparison of the antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination with captopril 50 mg/hydrochlorothiazide 25 mg fixed combination
Milon, H
Baleydier, A
[J]. THERAPIE, 1997, 52 (03): : 195 - 205
[3] Comparison of the antihypertensive effects of the candesartan 8 mg-hydrochlorothiazide 12.5 mg combination (C8+H) vs the valsartan 80 mg-hydrochlorothiazide 12.5 mg combination (V80+H) in patients with essential hypertension resistant to monotherapy
Azizi, M
Nisse-Durgeat, S
[J]. JOURNAL OF HYPERTENSION, 2004, 22 : S254 - S255
[4] Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy
Boenner, Gerd
[J]. BLOOD PRESSURE, 2008, 17 : 22 - 30
[5] MULTICENTER STUDY OF THE ANTIHYPERTENSIVE EFFECT OF LISINOPRIL (20 MG) AND A FIXED COMBINATION OF LISINOPRIL (20 MG) AND HYDROCHLOROTHIAZIDE (12.5 MG) ONCE-DAILY IN MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
CAMERA, MI
WAISMAN, GD
GALARZA, CR
ALFIE, J
ARAHABETY, A
SAGGESE, O
MAGI, MI
MAYORGA, LM
[J]. DRUG DEVELOPMENT RESEARCH, 1995, : 20 - 23
[6] Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension
Neldam, Steen
Schumacher, Helmut
Kjeldsen, Sverre E.
Neutel, Joel M.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (09) : 1715 - 1724
[7] Antihypertensive efficacy of hydrochlorothiazide 12.5 mg in patients with mild to moderate hypertension
Roque, F
Mon, G
Cravero, C
Courreges, J
Deschle, H
Scandone, M
Palumbo, JL
Ballester, AE
Murua, J
[J]. ADVANCES IN THERAPY, 1996, 13 (05) : 284 - 291
[8] Efficacy and tolerability of candesartan 16 mg plus hydrochlorothiazide 12.5 mg fixed combination vs. previous monotherapy plus hydrochlorothiazide in essential hypertension
Omboni, S
Mancia, G
[J]. JOURNAL OF HYPERTENSION, 2004, 22 : S256 - S256
[9] Evaluation by ambulatory blood pressure measurement of the antihypertensive effect of the fixed combination therapy valsartan 80 mg and hydrochlorothiazide 12.5 mg
Vaisse, B
Ghobrial, H
Vaur, L
Poncelet, P
Asmar, R
Herpin, D
Mallion, JM
[J]. JOURNAL OF HYPERTENSION, 2001, 19 (08) : A2 - A2
[10] Antihypertensive effect and tolerability of a low-dose combination of candesartan cilexetil and hydrochlorothiazide
Mimran, A
Cifková, R
Sándor, S
Wiecek, A
[J]. JOURNAL OF HYPERTENSION, 1998, 16 : S244 - S244

← 1 2 3 4 5 →